Expression Analysis® Expands Scientific Management Team
News Apr 28, 2010
Expression Analysis, Inc. has announced two additions to its scientific management team Patrick Hurban, Ph.D. and Louise Grant. Hurban will assume the role of Vice President of Research and Development and Grant, Director of Operations.
Dr. Hurban comes to Expression Analysis with a wealth of genomic experience, graduating from University of Utah School of Medicine with his Ph.D (Human Genetics) in 1994 and later performed his Postdoctoral Research at Stanford University School of Medicine in the Departments of Developmental Biology and Biochemistry; additionally he has held several positions of increasing responsibility in high-profile genomics-focused organizations. His research interests have focused on the genetic control of gene expression and have spanned diverse fields including toxicology as well as developmental and cancer biology. Hurban will be responsible for a group of Ph.D. scientists with specialized genomics expertise charged with providing new application and new technology development support to Expression Analysis and its client’s.
Ms. Grant comes to Expression Analysis with over twenty years experience in the clinical diagnostics industry. Her experience includes clinical laboratory work and research at John’s Hopkins Medical Institution in Baltimore as well as Research & Development, Technical Support and Product Management at Becton Dickinson. Most recently she was with bioMérieux as Microbiology Program Director. Grant’s responsibility will be to manage and expand laboratory capabilities in line with Expression Analysis’ strategic objectives, while ensuring optimal utilization of laboratory resources.
“We are excited to have Pat and Louise join our management team,” said Steve McPhail, CEO and President of Expression Analysis. “The talent and experience these individuals bring with them will add tremendous benefit to our clients as we enhance our infrastructure and increase our service offerings.”
Animal venoms are the subject of study at research center based at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets of diseases and, armed with that knowledge, develop new compounds that can be used as medicines.